Form 4 for ROIV Roivant Sciences Ltd.

Accepted 2023-04-24 00:00:00 ET · period of report 2023-04-20 · accession 0001140361-23-019991 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2023-04-24	2023-04-20	ROIV	Pulik Richard	CFO	A - Grant	$0.00	+66.7K	288.4K	+30%	$0
D	2023-04-24	2023-04-20	ROIV	Pulik Richard	CFO	A - Grant	$0.00	+383.5K	383.5K	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Shares	2023-04-20	A	A	66,710	$0.00	288,418	D	—	—	(F1) Reflects an award of 66,710 restricted stock units with respect to Common Shares ("RSUs") with a vesting commencement date of April 20, 2023. 1/4 of the RSUs service-vest twelve (12) months after the vesting commencement date; 1/16 of the RSUs service-vest fourteen (14) months after the vesting commencement date; and the balance of the RSUs service-vest in a series of eleven (11) successive equal quarterly installments measured from the date fourteen (14) months after the vesting commencement date, subject to the reporting person's Continuous Service through the applicable vesting date.
2	Derivative	Stock Option (Right to Buy)	2023-04-20	A	A	383,496	$0.00	383,496	D	$8.80 · — to 2033-04-19	383,496 Common Shares	(F2) Award of stock options to purchase Common Shares with a vesting commencement date of April 20, 2023. These options vest and become exercisable (i) 25% on the first anniversary of the vesting commencement date and (ii) in 36 equal monthly installments thereafter, subject to the reporting person's continuous service through each vesting date.